Active	Status	Sponsor type	Region	Phase	Filter
3 Active 1 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Perrot, Marc De
SUPER, NCT06331455: Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection	Recruiting	2	12	Canada	Durvalumab, Non-ablative oligofractionated radiation (NORT)	Marc de Perrot, Ozmosis Research Inc.	Lung Cancer Patients, Non-small Cell Lung Cancer (NSCLC)	12/25	04/26
NCT06191250: --SuPERIOR Trial--	Not yet recruiting	2	10	NA	Durvalumab, Non-ablative oligofractionated radiation (NORT)	University Health Network, Toronto, OICR	Non-Small Cell Lung Cancer (NSCLC), Clinical Staging T2b-3 N0-1 M0	03/25	12/25
NORTh STAR, NCT04782752: Non-ablative Oligofractionated Radiation Therapy Before Surgical Transplantation As Radiovaccination	Recruiting	N/A	42	Canada	Radiation: Varying Doses of RT	University Health Network, Toronto	Transplant-Related Lung Cancer	12/25	12/25